CD9 and cancer: Interestingly, 15-35% of cancer-associated stromal cells had nuclear CD9 signals at a frequency of 1.36 ± 0.14 (s.e.m.)per nucleus, while this event was rarely observed in distant stroma (Figure 7E, >100 vim+ cells were evaluated per patient, n = 3).